Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report

Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report

Immune checkpoint inhibitors (ICIs) increase T-cell activity and antitumor immune response. However, they also have immune-related adverse effects that can affect the gastrointestinal (GI) tract. A 62-year-old male patient who had undergone right lung upper lobectomy for adenocarcinoma of the lung r...

Full description

Bibliographic Details
Main Authors: Yasuhito Kunogi, Keiichi Tominaga, Keiichiro Abe, Mimari Kanazawa, Takanao Tanaka, Shoko Watanabe, Masayuki Kondo, Akira Kanamori, Makoto Iijima, Kenichi Goda, Yumi Nozawa, Kazuyuki Ishida, Atsushi Irisawa
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Healthcare
Subjects:
immune checkpoint inhibitor-induced enterocolitis
lung cancer
pembrolizumab
tacrolimus
Online Access:https://www.mdpi.com/2227-9032/9/4/418

Internet

https://www.mdpi.com/2227-9032/9/4/418

Similar Items